Sentence: A retrospective analysis was conducted on the clinical data of 122 advanced NSCLC patients with pleural effusion , and among them , 61 received thoracic hyperthermic perfusion with recombinant human endostatin ( ES ) plus nedaplatin ( Endostatin group ) , while the other 61 underwent thoracic hyperthermic perfusion with cisplatin alone ( Cisplatin group ) .
Drug combination annotation:
[{'class': 'POS', 'spans': ['endostatin', 'nedaplatin'], 'is_context_needed': True}]